Status:
WITHDRAWN
An Alternative Way To Deliver Oxygen To People
Lead Sponsor:
Christopher Bell
Collaborating Sponsors:
Respirogen Inc.
Conditions:
Hypoxia
Eligibility:
All Genders
18-40 years
Phase:
EARLY_PHASE1
Brief Summary
The availability of oxygen is a crucial prognostic indicator for outcomes pertinent to many chronic diseases. Accordingly, interventions that might increase oxygen availability have obvious beneficial...
Eligibility Criteria
Inclusion
- age between 18-40 years,
- body mass index between 19 and 30 kg/m\^2,
- resident at a similar altitude for a minimum of 1-year,
- no travel to/from areas varying by \~2000 feet of elevation within 4-weeks of initiation of study participation.
Exclusion
- identification of overt chronic disease (including cardio-pulmonary disorders),
- prior diagnosis of asthma, cystic fibrosis, Chronic obstructive pulmonary disease, or ventilator therapy
- anemia,
- pregnancy,
- habitual use of tobacco/nicotine products,
- known allergy to sodium phosphate (or other common laxatives),
- habitual use of recreational drugs that require inhalation,
- history of seizures, kidney problems, stomach or bowel problems, ulcerative colitis, problems with swallowing or gastric reflux, gout, and and/or low blood sodium.
- irritable bowel
- ACUTE respiratory illness such as bronchitis, pneumonia, Upper Respiratory Infection OR ACUTE GI issues such as gastroenteritis.
- Anemia (as measurement of hemoglobin and/or hematocrit) .
- sickle cell disease.
- history of altitude sickness
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04870801
Start Date
January 1 2022
End Date
January 1 2024
Last Update
June 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Colorado State University, Dept. of Health and Exercise Science
Fort Collins, Colorado, United States, 80523-1582